AstraZeneca PLC and Bristol-Myers Squibb Company to Present New Data at American Diabetes Association 73rd Scientific Sessions®

Published: Jun 14, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AstraZeneca (NYSE: AZN) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that 33 abstracts on the companies’ research in diabetes have been accepted for presentation at the 73rd Scientific Sessions® of the American Diabetes Association (ADA) in Chicago, June 21-25.

Help employers find you! Check out all the jobs and post your resume.

Back to news